Skip to main content
. 2018 Aug;18(8):874–883. doi: 10.1016/S1473-3099(18)30309-8

Figure 2.

Figure 2

Parasitaemia in the patients with Plasmodium falciparum malaria

Parasitaemia was measured by microscopy. Patients received a single oral dose at 0 h with 400 mg (A) or 250 mg (B) DSM265. Patient F2003 developed suspected bacteraemia, a serious, non-treatment-related adverse event, and was discontinued from the study.